Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects

Background: This research examined the effect of autologous serum eye drops (ASED) on ocular symptoms, visual-related functioning and quality of life for patients failing other therapies. Methods: Patients (N=77) were asked to complete a survey prior to ASED use, and 2 and 12 months post-treatment. Results: Significant improvements in symptom frequency and severity were documented for dryness, ocular pain and grittiness at 2 and 12 months. Patients felt more in control and required less help from others at 12 months. Conclusions: ASED produce sustained benefits to dry eye symptoms, improve feelings of control and reduce requirements for assistance from others.